Many known bioactive substances secreted by heart, including ANP, have been indicated to be involved in the regulation of cardiovascular disease and sensitive as indicators of disease monitoring (Ishimaru et al., 2017). This evidence concerns the gene NPPA and cardiovascular disorder.